In the news
ChrysCapital completes ₹1,446 crore acquisition of Novartis India
Novartis launches India's first radioligand therapy for prostate cancer
Novartis exits Indian arm for ₹1,446cr to ChrysCapital-led group
Novartis India shares surge 17% as ChrysCapital consortium completes buyout